Literature DB >> 496399

The beta-glucuronidase release from macrophages activated by immune complexes of varying antigen/antibody ratio.

J Pestel, M Joseph, F Santoro, A Capron.   

Abstract

When unstimulated rat peritoneal macrophages are exposed in vitro to IC formed with BSA and specific rat anti-BSA IgG antibodies, an exocytosis of the lysosomal beta-G occurs. The maximal release of beta-G into the serum-free medium is induced, without cell lysis, by IC after a 6-h contact with the adherent cell population. This phenomenon is dose-dependent, and the percentage of beta-G in the medium is higher with IC in Ab excess than with other types of IC. In this homologous model (rat macrophages and rat antibodies) the Ag/Ab ratio of IC seems to represent an important factor of macrophage activation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 496399

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  5 in total

1.  Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcgamma receptors.

Authors:  Yin Luo; Zhaojiang Lu; Stephen W Raso; Clifford Entrican; Bruce Tangarone
Journal:  MAbs       Date:  2009-09-24       Impact factor: 5.857

2.  Membrane and functional characterization of lymphoid and macrophage populations of Peyer's patches from adult and aged mice.

Authors:  V Vĕtvicka; H Tlaskalová-Hogenová; L Fornůsek; B Ríhová; V Holán
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

3.  Release of lysosomal enzymes in Candida albicans phagocytosis by rat peritoneal macrophages.

Authors:  S E Fontenla de Petrino; A Sirena
Journal:  Mycopathologia       Date:  1984-02-15       Impact factor: 2.574

4.  Macrophage triggering by aggregated immunoglobulins. II. Comparison of IgE and IgG aggregates or immune complexes.

Authors:  J Pestel; J P Dessaint; M Joseph; H Bazin; A Capron
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

5.  Signals of monocyte activation in patients with SLE.

Authors:  M Kávai; A Zsindely; I Sonkoly; M Major; I Demján; G Szegedi
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.